Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic.
作者信息
Mohr-Holland Erika, Douglas-Jones Bianca, Apolisi Ivy, Ngambu Noluvo, Mathee Shaheed, Cariem Rabia, Mudaly Vanessa, Pfaff Colin, Isaakidis Petros, Furin Jennifer, Reuter Anja
机构信息
Médecins Sans Frontières, Cape Town, South Africa.
Department of Health, Cape Town, South Africa.
出版信息
Lancet Child Adolesc Health. 2021 Mar;5(3):159-161. doi: 10.1016/S2352-4642(21)00003-1.
Abstract
摘要
相似文献
1
Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic.儿童和青少年结核病预防性治疗：对 COVID-19 大流行的应急响应
Lancet Child Adolesc Health. 2021 Mar;5(3):159-161. doi: 10.1016/S2352-4642(21)00003-1.
2
Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.耐多药结核病患儿接触者的预防治疗：一项前瞻性队列研究。
Clin Infect Dis. 2013 Dec;57(12):1676-84. doi: 10.1093/cid/cit655. Epub 2013 Sep 24.
3
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.贝达喹啉在儿童和青少年耐多药结核病中的超说明书使用。
Emerg Infect Dis. 2017 Oct;23(10):1711-3. doi: 10.3201/eid2310.170303. Epub 2017 Oct 17.
4
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis.耐多药结核病暴露的幼儿中新型左氧氟沙星分散片制剂的可接受性。
Pediatr Infect Dis J. 2019 Jun;38(6):608-610. doi: 10.1097/INF.0000000000002268.
5
Extensively drug-resistant tuberculosis in South Africa.
Lancet. 2007 Jan 27;369(9558):272-3. doi: 10.1016/S0140-6736(07)60143-3.
6
Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children.儿童结核病治疗的最新进展和未来机遇。
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S188-99. doi: 10.1093/cid/civ582.
7
[Multidrug-resistant tuberculosis in children: about two cases].[儿童耐多药结核病：两例报告]
Pan Afr Med J. 2016 Mar 25;23:126. doi: 10.11604/pamj.2016.23.126.9041. eCollection 2016.
8
Linezolid in children with drug resistant tuberculosis.
Infect Dis (Lond). 2018 Nov-Dec;50(11-12):868-870. doi: 10.1080/23744235.2018.1500710. Epub 2018 Oct 8.
9
DOTS and DOTS-Plus: what's in a name.
Int J Tuberc Lung Dis. 2000 Nov;4(11):995-6.
10
A poor drug-resistant tuberculosis programme is worse than no programme: time for a change.一个糟糕的耐多药结核病防治项目比没有项目更糟糕：是时候做出改变了。
Int J Tuberc Lung Dis. 2013 Jun;17(6):714-8. doi: 10.5588/ijtld.12.0989. Epub 2013 Apr 9.
引用本文的文献
1
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.2020 - 2023年新冠疫情对结核病的全球影响：一项主题范围综述
PLOS Glob Public Health. 2024 Jul 3;4(7):e0003043. doi: 10.1371/journal.pgph.0003043. eCollection 2024.
2
Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance.耐药结核病和 COVID-19：对抗菌药物耐药性新威胁的范围综述。
Rev Bras Enferm. 2023 Dec 4;76Suppl 1(Suppl 1):e20220803. doi: 10.1590/0034-7167-2022-0803. eCollection 2023.
3
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis.将感染治疗作为预防利福平耐药/耐多药结核病的核心策略
Pathogens. 2023 May 17;12(5):728. doi: 10.3390/pathogens12050728.
4
Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now.儿童中的耐多药结核病（MDR-TB）和广泛耐药结核病（XDR-TB）：我们目前的状况
Cureus. 2023 Feb 18;15(2):e35154. doi: 10.7759/cureus.35154. eCollection 2023 Feb.
5
Review of Pediatric Tuberculosis in the Aftermath of COVID-19.新冠疫情后儿童结核病综述
Clin Pract. 2022 Sep 11;12(5):738-754. doi: 10.3390/clinpract12050077.
6
Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol.基里巴斯全国性主动病例发现和结核病与麻风病消除预防：PEARL 研究方案。
BMJ Open. 2022 Apr 12;12(4):e055295. doi: 10.1136/bmjopen-2021-055295.
7
Atypical presentation of acquired tracheo-oesophageal fistula in an adolescent girl with pulmonary tuberculosis.青少年肺结核患者获得性气管食管瘘的非典型表现。
BMJ Case Rep. 2022 Feb 28;15(2):e242384. doi: 10.1136/bcr-2021-242384.
8
Integrating health planning and primary care infrastructure for COVID-19 and tuberculosis care in India: Challenges and opportunities.将新冠疫情和结核病防治工作纳入印度的卫生规划和初级医疗基础设施：挑战与机遇。
Int J Health Plann Manage. 2022 Mar;37(2):632-642. doi: 10.1002/hpm.3393. Epub 2021 Nov 24.
9
Tuberculosis in times of COVID-19.COVID-19 时期的结核病。
J Epidemiol Community Health. 2022 Mar;76(3):310-316. doi: 10.1136/jech-2021-217529. Epub 2021 Sep 17.
本文引用的文献
1
Building a tuberculosis-free world while responding to the COVID-19 pandemic.在应对新冠疫情的同时建立无结核病的世界。
Lancet. 2020 Oct 24;396(10259):1312-1313. doi: 10.1016/S0140-6736(20)32138-3.
2
Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target.2019冠状病毒病（COVID-19）时代的结核病消除：一个不断变化的目标。
Clin Infect Dis. 2022 Feb 11;74(3):509-510. doi: 10.1093/cid/ciaa1400.
3
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.欧洲儿童和青少年中的 COVID-19：一项多国家、多中心队列研究。
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661. doi: 10.1016/S2352-4642(20)30177-2. Epub 2020 Jun 25.
4
Scaling up tuberculosis preventive therapy for contacts in high transmission settings.扩大高传播环境中针对接触者的结核病预防性治疗规模。
Lancet Glob Health. 2020 May;8(5):e617-e618. doi: 10.1016/S2214-109X(20)30133-9.
5
Challenges and controversies in childhood tuberculosis.儿童结核病面临的挑战和争议。
Lancet. 2019 Sep 14;394(10202):967-978. doi: 10.1016/S0140-6736(19)32045-8.
6
Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.耐多药结核病的感染控制：早期诊断和治疗是关键。
Clin Infect Dis. 2016 May 15;62 Suppl 3(Suppl 3):S238-43. doi: 10.1093/cid/ciw012.
7
Caring for children with drug-resistant tuberculosis: practice-based recommendations.关爱耐多药结核病患儿：基于实践的建议。
Am J Respir Crit Care Med. 2012 Nov 15;186(10):953-64. doi: 10.1164/rccm.201206-1001CI. Epub 2012 Sep 13.
Zotero 插件